Destination Wealth Management Vertex Pharmaceuticals Inc Transaction History

Destination Wealth Management

$3.19 Billion
Q3 2024

A detailed history of Destination Wealth Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Destination Wealth Management holds 3,361 shares of VRTX stock, worth $1.37 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,361

Previous 3,217 4.48%

Holding current value

$1.37 Million

Previous $1.51 Million 3.72%

% of portfolio

0.05%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 25, 2024	BUY	$460.0 - $505.78 $66,240 - $72,832	144 Added 4.48%	3,361 $1.56 Million
Q2 2024 Jul 24, 2024	BUY	$392.81 - $485.53 $6,677 - $8,254	17 Added 0.53%	3,217 $1.51 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $1,223 - $1,338	3 Added 0.09%	3,200 $1.34 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $36,701 - $43,942	107 Added 3.46%	3,197 $1.3 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $676 - $724	-2 Reduced 0.06%	3,090 $1.07 Million
Q1 2023 May 05, 2023	SELL	$283.23 - $323.1 $28,323 - $32,310	-100 Reduced 3.13%	3,092 $974,000
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $28,576 - $32,148	100 Added 3.23%	3,192 $921,000
Q2 2022 Jul 29, 2022	SELL	$234.96 - $292.55 $1,409 - $1,755	-6 Reduced 0.19%	3,092 $871,000
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $2,435 - $2,870	11 Added 0.36%	3,098 $808,000
Q3 2021 Oct 25, 2021	SELL	$181.39 - $202.99 $7,981 - $8,931	-44 Reduced 1.41%	3,087 $560,000
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $562 - $663	3 Added 0.1%	3,131 $631,000
Q1 2021 May 05, 2021	BUY	$207.02 - $241.31 $1,449 - $1,689	7 Added 0.22%	3,128 $672,000
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $4,761 - $6,350	23 Added 0.74%	3,121 $738,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $78,241 - $102,642	-347 Reduced 10.07%	3,098 $899,000
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $688,207 - $853,705	3,445 New	3,445 $820,000
Q2 2019 Jul 19, 2019	SELL	$164.61 - $190.37 $2,798 - $3,236	-17 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$163.73 - $194.7 $2,783 - $3,309	17 New	17 $3,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.

Account

Destination Wealth Management Vertex Pharmaceuticals Inc Transaction History